3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
153
Lung Neoplasms
73
Pancreatic Neoplasms
44
Neoplasms
27
Neoplasm Metastasis
25
Head and Neck Neoplasms
23
Brain Neoplasms
21
Breast Neoplasms
18
Glioblastoma
15
Adenocarcinoma of Lung
15
Squamous Cell Carcinoma of Head and Neck
14
Gliosarcoma
14
Adenocarcinoma, Bronchiolo-Alveolar
11
Colorectal Neoplasms
10
Glioma
9
Carcinoma, Squamous Cell
8
Carcinoma, Hepatocellular
8
Adenocarcinoma
7
Rectal Neoplasms
6
Prostatic Neoplasms
6
Esophageal Neoplasms
6
Central Nervous System Neoplasms
6
Carcinoma, Renal Cell
6
Astrocytoma
6
Oligodendroglioma
5
Liver Neoplasms
5
Colonic Neoplasms
5
Carcinoma
5
Recurrence
4
Ovarian Neoplasms
4
Interventions
Gefitinib
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Stage Non Small Cell Lung Cancer
×
Erlotinib Hydrochloride
×
Clear all
NCT01955421
2015-07-03
NSCLC EGFR TKI
Sun Yat-sen University
Phase 2
Unknown
224 enrolled